First Time Loading...

AtriCure Inc
NASDAQ:ATRC

Watchlist Manager
AtriCure Inc Logo
AtriCure Inc
NASDAQ:ATRC
Watchlist
Price: 23.05 USD -0.52% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

ATRC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. [ Read More ]

The intrinsic value of one ATRC stock under the Base Case scenario is 52.11 USD. Compared to the current market price of 23.05 USD, AtriCure Inc is Undervalued by 56%.

Key Points:
ATRC Intrinsic Value
Base Case
52.11 USD
Undervaluation 56%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
AtriCure Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ATRC stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
AtriCure Inc

Provide an overview of the primary business activities
of AtriCure Inc.

What unique competitive advantages
does AtriCure Inc hold over its rivals?

What risks and challenges
does AtriCure Inc face in the near future?

Has there been any significant insider trading activity
in AtriCure Inc recently?

Summarize the latest earnings call
of AtriCure Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AtriCure Inc.

Provide P/S
for AtriCure Inc.

Provide P/E
for AtriCure Inc.

Provide P/OCF
for AtriCure Inc.

Provide P/FCFE
for AtriCure Inc.

Provide P/B
for AtriCure Inc.

Provide EV/S
for AtriCure Inc.

Provide EV/GP
for AtriCure Inc.

Provide EV/EBITDA
for AtriCure Inc.

Provide EV/EBIT
for AtriCure Inc.

Provide EV/OCF
for AtriCure Inc.

Provide EV/FCFF
for AtriCure Inc.

Provide EV/IC
for AtriCure Inc.

Show me price targets
for AtriCure Inc made by professional analysts.

What are the Revenue projections
for AtriCure Inc?

How accurate were the past Revenue estimates
for AtriCure Inc?

What are the Net Income projections
for AtriCure Inc?

How accurate were the past Net Income estimates
for AtriCure Inc?

What are the EPS projections
for AtriCure Inc?

How accurate were the past EPS estimates
for AtriCure Inc?

What are the EBIT projections
for AtriCure Inc?

How accurate were the past EBIT estimates
for AtriCure Inc?

Compare the revenue forecasts
for AtriCure Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AtriCure Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AtriCure Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of AtriCure Inc compared to its peers.

Compare the P/E ratios
of AtriCure Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing AtriCure Inc with its peers.

Analyze the financial leverage
of AtriCure Inc compared to its main competitors.

Show all profitability ratios
for AtriCure Inc.

Provide ROE
for AtriCure Inc.

Provide ROA
for AtriCure Inc.

Provide ROIC
for AtriCure Inc.

Provide ROCE
for AtriCure Inc.

Provide Gross Margin
for AtriCure Inc.

Provide Operating Margin
for AtriCure Inc.

Provide Net Margin
for AtriCure Inc.

Provide FCF Margin
for AtriCure Inc.

Show all solvency ratios
for AtriCure Inc.

Provide D/E Ratio
for AtriCure Inc.

Provide D/A Ratio
for AtriCure Inc.

Provide Interest Coverage Ratio
for AtriCure Inc.

Provide Altman Z-Score Ratio
for AtriCure Inc.

Provide Quick Ratio
for AtriCure Inc.

Provide Current Ratio
for AtriCure Inc.

Provide Cash Ratio
for AtriCure Inc.

What is the historical Revenue growth
over the last 5 years for AtriCure Inc?

What is the historical Net Income growth
over the last 5 years for AtriCure Inc?

What is the current Free Cash Flow
of AtriCure Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for AtriCure Inc.

Financials

Balance Sheet Decomposition
AtriCure Inc

Current Assets 266.2m
Cash & Short-Term Investments 137.3m
Receivables 52.5m
Other Current Assets 76.5m
Non-Current Assets 347.7m
PP&E 46.8m
Intangibles 298.8m
Other Non-Current Assets 2.2m
Current Liabilities 74.6m
Accounts Payable 27.4m
Accrued Liabilities 46.1m
Other Current Liabilities 1.1m
Non-Current Liabilities 73.2m
Long-Term Debt 68.7m
Other Non-Current Liabilities 4.5m
Efficiency

Earnings Waterfall
AtriCure Inc

Revenue
399.2m USD
Cost of Revenue
-98.9m USD
Gross Profit
300.4m USD
Operating Expenses
-327.1m USD
Operating Income
-26.7m USD
Other Expenses
-3.8m USD
Net Income
-30.4m USD

Free Cash Flow Analysis
AtriCure Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ATRC Profitability Score
Profitability Due Diligence

AtriCure Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
ROE is Increasing
42/100
Profitability
Score

AtriCure Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

ATRC Solvency Score
Solvency Due Diligence

AtriCure Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
Low D/E
69/100
Solvency
Score

AtriCure Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATRC Price Targets Summary
AtriCure Inc

Wall Street analysts forecast ATRC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRC is 57.27 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.

Lowest
Price Target
42.42 USD
84% Upside
Average
Price Target
57.27 USD
148% Upside
Highest
Price Target
68.25 USD
196% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ATRC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ATRC Price
AtriCure Inc

1M 1M
-18%
6M 6M
-33%
1Y 1Y
-45%
3Y 3Y
-65%
5Y 5Y
-18%
10Y 10Y
+38%
Annual Price Range
23.05
52w Low
22.71
52w High
57.73
Price Metrics
Average Annual Return 18.89%
Standard Deviation of Annual Returns 41.85%
Max Drawdown -74%
Shares Statistics
Market Capitalization 1.1B USD
Shares Outstanding 48 374 600
Percentage of Shares Shorted 6.92%

ATRC Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

AtriCure Inc Logo
AtriCure Inc

Country

United States of America

Industry

Health Care

Market Cap

1.1B USD

Dividend Yield

0%

Description

AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 875 full-time employees. The company went IPO on 2005-08-05. The company develops, manufactures, and sells devices for the surgical ablation of cardiac tissue, systems designed for the exclusion of the left atrial appendage and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers. Its ablation and left atrial appendage management (LAAM) products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its products for appendage management include AtriClip System and LARIAT System.

Contact

OHIO
Mason
7555 Innovation Way
+15137554100.0
https://www.atricure.com

IPO

2005-08-05

Employees

875

Officers

CEO, President & Director
Mr. Michael H. Carrel
Chief Financial Officer
Ms. Angela L. Wirick CPA
Chief Operating Officer
Mr. Douglas J. Seith
Chief Marketing & Strategy Officer
Mr. Justin J. Noznesky
Chief Human Resources Officer
Ms. Deborah Yount
Chief Technical Officer
Mr. Salvatore Privitera J.D.
Show More
Chief Scientific Officer
Dr. Vinayak Doraiswamy Ph.D.
Chief Legal Officer
Mr. Karl S. Dahlquist CCEP, J.D.
Vice President of Corporate Marketing & Communications
Valerie Storch-Willhaus
Show Less

See Also

Discover More
What is the Intrinsic Value of one ATRC stock?

The intrinsic value of one ATRC stock under the Base Case scenario is 52.11 USD.

Is ATRC stock undervalued or overvalued?

Compared to the current market price of 23.05 USD, AtriCure Inc is Undervalued by 56%.